Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002052113-25-003599
Filing Date
2025-10-17
Accepted
2025-10-17 12:45:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5656
2 EXHIBIT 24: POWER OF ATTORNEY PowerOfAttorney.txt EX-24 2924
3 EXHIBIT 99: ITEM 7 Item_7.txt EX-99 418
  Complete submission text file 0002052113-25-003599.txt   10847
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Subject) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-45573 | Film No.: 251399669
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 50 HUDSON YARDS NEW YORK NY 10001
Business Address 50 HUDSON YARDS NEW YORK NY 10001 (212) 810-5800
BlackRock Portfolio Management LLC (Filed by) CIK: 0002052113 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G